Role of cardiac magnetic resonance in stratifying arrhythmogenic risk in mitral valve prolapse patients: a systematic review and meta-analysis - Takeaways - MDSpire

Role of cardiac magnetic resonance in stratifying arrhythmogenic risk in mitral valve prolapse patients: a systematic review and meta-analysis

  • By

  • Marco Gatti

  • Ambra Santonocito

  • Francesco Pio Papa

  • Fabrizio D’Ascenzo

  • Ovidio De Filippo

  • Guglielmo Gallone

  • Anna Palmisano

  • Lorenzo Pistelli

  • Gaetano Maria De Ferrari

  • Antonio Esposito

  • Carla Giustetto

  • Paolo Fonio

  • Riccardo Faletti

  • June 6, 2024

  • 0 min

Share

  • 1

    Mitral valve prolapse (MVP) affects 2-3% of the population and can lead to malignant ventricular arrhythmias and sudden cardiac death in a subset of patients.

  • 2

    A subgroup known as Arrhythmic mitral valve prolapse (AMVP) is at higher risk for sudden cardiac death, highlighting the need for effective diagnostic strategies.

  • 3

    Cardiac magnetic resonance (CMR) plays a crucial role in risk stratification for MVP patients, assessing factors like left ventricle size and mitral regurgitation severity.

  • 4

    The systematic review aims to analyze CMR features that differentiate between patients with complex ventricular arrhythmias and those without.

  • 5

    The study will utilize databases like PubMed and Cochrane to gather relevant research, ensuring comprehensive data extraction and risk of bias assessment.

Original Source(s)

Role of cardiac magnetic resonance in stratifying arrhythmogenic risk in mitral valve prolapse patients: a systematic review and meta-analysis

  • by Marco Gatti, Ambra Santonocito, Francesco Pio Papa, Fabrizio D’Ascenzo, Ovidio De Filippo, Guglielmo Gallone, Anna Palmisano, Lorenzo Pistelli, Gaetano Maria De Ferrari, Antonio Esposito, Carla Giustetto, Paolo Fonio, Riccardo Faletti

  • June 6, 2024

Related Content

AI Scribes: Efficiency for Whom?

Unresolved safety, privacy, and regulatory concerns may limit benefits of AI scribes for physicians and patients.

Is Long COVID Affecting the Heart?

Study points to increased cardiovascular events post-infection

  • April 17, 2026

  • 2 min
Retroperitoneal and pelvic schwannoma/neurofibroma resection: surgical strategies and outcomes in a neurosurgical cohort